KLTO
Price:
$0.49
Market Cap:
$25.82M
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
KLTO
According to Klotho Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.48M. This represents a change of 2.38% compared to the average of 18.05M of the last 4 quarters.
The mean historical Enterprise Value of Klotho Neurosciences, Inc. over the last ten years is 863.29M. The current 18.48M Enterprise Value has changed 114.02% with respect to the historical average. Over the past ten years (40 quarters), KLTO's Enterprise Value was at its highest in in the March 2024 quarter at 1.08B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
863.29M
Median
1.08B
Minimum
9.54M
Maximum
1.08B
Discovering the peaks and valleys of Klotho Neurosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0.15%
Maximum Annual Enterprise Value = 1.08B
Minimum Annual Increase = -99.11%
Minimum Annual Enterprise Value = 9.54M
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 9.54M | -99.11% |
| 2023 | 1.08B | 0.02% |
| 2022 | 1.08B | 0.15% |
| 2021 | 1.08B | 0.00% |
The current Enterprise Value of Klotho Neurosciences, Inc. (KLTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
721.56M
5-year avg
863.29M
10-year avg
863.29M
Klotho Neurosciences, Inc.’s Enterprise Value is less than Cadrenal Therapeutics, Inc. Common Stock (19.18M), less than Rallybio Corporation (18.77M), less than Exicure, Inc. (35.58M), less than Minerva Neurosciences, Inc. (70.91M), greater than iBio, Inc. (-4380600.00), less than NeuroSense Therapeutics Ltd. (28.93M), greater than Sonnet BioTherapeutics Holdings, Inc. (8.18M), greater than TAO Synergies Inc. (8.89M), greater than MetaVia Inc. (-1392365.00), less than NeurAxis, Inc. (24.74M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 19.18M | $23.04M | |
| 18.77M | $28.16M | |
| 35.58M | $42.96M | |
| 70.91M | $26.16M | |
| -4380600.00 | $21.16M | |
| 28.93M | $29.60M | |
| 8.18M | $8.43M | |
| 8.89M | $23.26M | |
| -1392365.00 | $16.10M | |
| 24.74M | $28.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klotho Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Klotho Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Klotho Neurosciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
What is the 3-year average Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
What is the 5-year average Enterprise Value for Klotho Neurosciences, Inc. (KLTO)?
How does the current Enterprise Value for Klotho Neurosciences, Inc. (KLTO) compare to its historical average?